selling price escalated in tandem with upward CPO price compared to prior year. In 2Q2020, the Company had total sales revenue of THB 3,931 million, rose by THB 641 million or 19% compared to 2Q2019, even
Yai, Chachoengsao, Rayong and Diana Hat Yai Branch. Industry Overview Thailand’s overall economy expanded at a slower pace than expected in 2Q19 due to external demand. The escalated trade tension
significantly escalated from 1Q2019 thanks to the Government’ s announcement of B10 biodiesel as the mandatory diesel in Thailand replacing B7 biodiesel from January 1, 2020 onwards and the increasing of the B10
persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator
transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
was rising by 6.1 percent; the highest growth in ASK was from Asia-Pacific at 7.9 percent, following by the Middle East and Europe which escalated by 7.5 percent and 6.3 percent respectively. The